Laparoscopic gastrectomy in Western European patients with advanced gastric cancer. Issue 1 (January 2016)

• Record Type: Journal Article
• Authors: Haverkamp, L.; Ruurda, J.P.; Offerhaus, G.J.A.; Weijs, T.J.; van der Sluis, P.C.; van Hillegersberg, R.
• Is Part Of: European journal of surgical oncology. Volume 42:Issue 1(2016:Jan.)
• Page Start: 110
• Page End: 115
• Publication Date: 2016-01
• Subjects: Gastric cancer -- Total gastrectomy -- Laparoscopy -- Neoplasm -- Minimally invasive -- Surgery; Oncology -- Periodicals; Cancer -- Surgery -- Periodicals; Medical Oncology -- Periodicals; Neoplasms -- surgery -- Periodicals; Cancer -- Chirurgie -- Périodiques; Cancérologie -- Périodiques; Oncologie; Chirurgie (geneeskunde); Electronic journals; Electronic journals -- Sciences; Electronic journals -- Medicine; Electronic journals; 616.994059005
• DOI: 10.1016/j.ejso.2015.09.018
• Languages: English
• ISSNs: 0748-7983

Abstract

Abstract: Background: The advantage of laparoscopic gastrectomy compared to open gastrectomy has been established in Asian patient series with early gastric cancer. However, its feasibility in Western European patients with locally advanced gastric cancer is unknown. Methods: Between 2006 and 2014 70 consecutive patients with advanced gastric cancer underwent laparoscopic gastrectomy with D2 lymph node dissection. A Billroth II reconstruction was performed after distal gastrectomy. In case of total gastrectomy a jejunal J-pouch reconstruction was performed. Results: Total gastrectomy was performed in 56 patients and distal gastrectomy in 14 patients. Perioperative chemotherapy was administered in 45/70 (64%) patients. A radical resection was achieved in 63/70 (90%). The median number of dissected lymph nodes was 17 (2–62). The median intraoperative blood loss was 305 (30–2700) milliliters. The median postoperative hospital stay was 11 (5–91) days. The 30-day mortality was 4.3%. Conclusions: Laparoscopic gastrectomy can be performed in Western European patients with advanced gastric cancer and meets the oncologic standard with low intraoperative blood loss and short hospital stay.